Attention during treatment and chemotherapy

Oncological and chemotherapy care patients are given a fixed time for each time they take an oral drug and a chemotherapy drug to facilitate stable blood concentration. It is also subject to the prescription of the attending physician, to take the medication at its own rate and not to increase or reduce the quantity of the drug. It is possible to know in advance how to identify and respond to the common adverse effects of target-oriented and chemotherapy drugs. They can be stored in accordance with the drug instructions and are generally kept at constant temperatures to avoid long periods of suntan and damp conditions that affect the efficacy of the drug. Oncological patients are more likely to be exposed to medications during their treatment, and there is frequent leakage. In cases of non-compliance with different oral anti-oncological drugs, treatment should be based on the requirements of the medical instructions, and some patients who have taken drugs have been vomiting and are not recommended for replacement. In order to avoid drug leaks, patients can prepare a drug recorder card, or they can warn them by setting alarm clocks, binding incidents, and setting a fixed location, for example by placing two incidents of washing and taking drugs together, taking them after washing them, or placing them in bedside cabinets to remind themselves to take them on time. Patients can develop different methods to avoid drug leaks based on their habits and habits. Patients also need to be routinely tested for blood pressure during anti-tumour treatment, and when blood pressure abnormalities (generally, more than 140/90 mm mercury column) and symptoms such as dizziness, nausea, vomiting, etc. are reported immediately, and blood pressure data and medications are made available to doctors to avoid delays. In terms of diet, patients avoid eating foods such as grapefruit and grape juice during oral anti-cancer drugs, which have a related effect on blood concentrations of the drugs. Patients live on a daily basis, wearing relatively relaxed clothing, avoiding skin frictions, with conditions that enhance skin humidification, avoid long periods of sunlight and take care to guard against sun. Skin-related adverse effects occur in some patients during drug use, often mainly in the form of rashes, scabies and gourmet, which are relatively sufficient for treatment. Oncological treatment is a long process and regular follow-up visits are necessary. Regular follow-up visits can assess the effects of treatment, as well as early detection or transfer of tumours, identification and timely intervention of adverse effects, adjustment of the drug programme and improvement of the prognosis. The follow-up visits consist of three main components: pre-visit consultations, follow-up related materials, and follow-up projects that may require inspection. The consultations prior to the follow-up included the examination project that may be involved, the examination of the need for an empty stomach, etc., and the advance communication of the next clinic with experts. Related follow-up materials include past-inspection reports, records of adverse effects, medical records (types of drugs taken, dosages, frequency, etc.). Follow-up projects that may require inspection include: medical examination, blood protocol, low-dose spiral CT, B super, skull enhancement MRI, etc. Patients are required to confirm the frequency of follow-up visits with the attending physician, such as early, mid- and end-of-life lung cancer: patients with 1 to 3 years of illness are recommended for review once every 3 to 6 months; patients with 4 to 5 years are recommended for review once a year; after 5 years, it is recommended for review once a year. Patients with partial or non-surgery advanced lung cancer follow up: patients with no symptoms or stable symptoms, 1 visit every 8 to 12 weeks; patients with new symptoms and aggravated symptoms in clinical settings are immediately referred back. Oncological patients are regularly followed up and benefit from assisted treatment.